New hormonal approaches for osteoporosis on the horizon

Abstract

A number of studies involving the use of new non-estrogen hormones for the treatment of either postmenopausal or corticosteroid-induced osteoporosis demonstrate the promise of these agents as emerging therapeutic modalities. Results from some of these studies were presented at the 19th Annual Meeting of the American Society of Bone and Mineral Research [ Cincinnati, US, September 1997 ].